Contact us

Contact us

US Headquarters:
Dystrogen Therapeutics Corporation
1415 W 37th Street
Chicago, Illinois

EU R&D:
Dystrogen Therapeutics
ul. Kasztelańska 49
Poznań 60-316, PL
NIP: 7792482313

Correspondence address:
USA:
Dystrogen Therapeutics Corporation,
1415 W 37th Street,
Chicago, Illinois

Warsaw Office:
ul. Pytlasińskiego 10/12 lok. 14
00-777 Warszawa, PL

General inquiries: info@dystrogen.com

Investor Relations Contacts: investor@dystrogen.com
Marta Oseka
Vice President of Business Development and Investor Relations
oseka@dystrogen.com